Zimmer Biomet launches clinical service biz

Zimmer Biomet (NYSE:ZBH) said today it is launching Signature Solutions, a suite of clinical services designed to assist hospitals and medical practices to transition to value-based healthcare models.

The company said it will aid companies in moving to the new models by maintaining positive patient outcomes and managing procedural and cost efficiencies through an entire episode of care.

The services aim to assist healthcare providers as they try to meet value-based healthcare mandates, such as the Comprehensive Care for Joint Replacement act and the Medicare Access and CHIP Reauthorization Act of 2015.

“Our 90-year legacy and leadership in musculoskeletal healthcare, coupled with more than a decade of consulting experience delivering measurably improved outcomes for large and small institutions worldwide, gives Zimmer Biomet a deep understanding of the levers driving success in the value-based healthcare environment. Signature Solutions will encapsulate our exclusive and extensive knowledge of the new healthcare landscape into the 1st end-to-end suite of clinical services, technologies and proprietary analytical tools, which are designed to work seamlessly with the institutions’ existing infrastructure to improve quality outcomes, provide more efficient care and increase provider throughput,” CEO David Dvorak said in a press release.

The Signature Solutions biz has roots in the mid-1990s when Zimmer launched its consulting services as the healthcare economy shifted towards a value-based model, the company said. The newly launched biz will integrate Zimmer Biomet’s established consulting platform as well as a curated suite of other applications and services.

“As patient outcomes figure more prominently in the bundled payment environment, healthcare institutions are under increased pressure to minimize inefficiencies along the entire episode of care while delivering superior quality of care and a positive patient experience. Over the past year, we engaged Signature Solutions’ expert consulting services to guide our clinical and operational teams to improve the value of our orthopaedic program by creating standards for patient optimization and surgical performance.  The new technologies and digital software components will further enhance the utility ofSignature Solutions and provide healthcare institutions with an all-in-one solution to optimize performance in a value-based care model,” Dr. Todd Dietrick of Pasadena, Calif.’as Huntington Memorial Hospital said in prepared remarks.

The initial offering through Signature Solutions will be a comprehensive suite of musculoskeletal healthcare service lines at select academic facilities in the U.S. The company said it is planning a broader release next year.

“We’re excited to redefine the meaning of innovation in our sector with the launch of Signature Solutions, a truly unique and differentiated offering that successfully leverages our technological expertise, industry know-how, strategic alliances and extensive network of institutional relationships. We look forward to a broad-scale launch of Signature Solutions timed to coincide with institutions seeking ways to redesign care protocols and identify potential cost saving opportunities in the new bundled payment environment,” Dvorak said in a prepared statement.

Earlier this month, Zimmer Biomet said it agreed to pay at least $132 million to acquire French robot-assisted surgery firm Medtech (EPA:ROSA).

Warsaw, Ind.-based Zimmer Biomet has already paid €50.00 per share ($55.39) for more than 1.4 million ROSA shares, which is about 58.77% of the Montpellier, France-based company’s stock, to founder & CEO Bertin Nahum, Newfund and other owners. Zimmer Biomet also put up €50.03 ($55.43) for per Medtech’s convertible bonds and €17.17  ($19.02) for its warrants, both of which were owned by Ally Bridge Group.

Zimmer Biomet said it also agreed to launch and all-cash tender offer for the Medtech shares it doesn’t already own, subject to the approval of France’s anti-trust watchdog, the Autorité des Marchés Financiers.

The post Zimmer Biomet launches clinical service biz appeared first on MassDevice.

from MassDevice http://ift.tt/2as6HcW